Statistical Analysis Code: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL OF TAMOXIFEN COMBINED WITH AMPHOTERICIN B AND FLUCONAZOLE FOR CRYPTOCOCCAL MENINGITIS
These code were created in 2020 and 2021 to analyse the clinical trial: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL OF TAMOXIFEN COMBINED WITH AMPHOTERICIN B AND FLUCONAZOLE FOR CRYPTOCOCCAL MENINGITIS. The deposit consists of R and SAS code to analyse the trial dataset. The programmes R and SAS are...
Main Authors: | Ngan, N, Day, J, Le, N |
---|---|
Format: | Dataset |
Language: | English |
Published: |
University of Oxford
2021
|
Subjects: |
Similar Items
-
An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis
by: Nguyen Thi Thuy Ngan, et al.
Published: (2021-09-01) -
Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis
by: Edward Mpoza, et al.
Published: (2018-03-01) -
Extended data - Appendices - A randomised controlled trial of tamoxifen for cryptococcal meningitis
by: Day, J
Published: (2019) -
A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis
by: Ngan, N, et al.
Published: (2019) -
An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis
by: Ngan, NTT, et al.
Published: (2021)